WFRF:(Bartoletti A)
Sökning: WFRF:(Bartoletti A) > Recurrence, progres...
LIBRIS Formathandbok (Information om MARC21)
| Fältnamn | Indikatorer | Metadata |
|---|---|---|
| 000 | 06049naa a2200685 4500 | |
| 001 | oai:DiVA.org:uu-366942 | |
| 003 | SwePub | |
| 008 | 181128s2018 | |||||||||||000 ||eng| | |
| 024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3669422 URI |
| 024 | 7 | a https://doi.org/10.1007/s00345-018-2299-22 DOI |
| 040 | a (SwePub)uu | |
| 041 | a engb eng | |
| 042 | 9 SwePub | |
| 072 | 7 | a ref2 swepub-contenttype |
| 072 | 7 | a art2 swepub-publicationtype |
| 100 | 1 | a Palou, J.u Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain4 aut |
| 245 | 1 0 | a Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG :b not as bad as previously thought |
| 264 | c 2018-05-02 | |
| 264 | 1 | b SPRINGER,c 2018 |
| 338 | a print2 rdacarrier | |
| 520 | a Purpose: The goals of transurethral resection of a bladder tumor (TUR) are to completely resect the lesions and to make a correct diagnosis to adequately stage and treat the patient. Persistent disease after TUR is not uncommon and is why re-TUR is recommended in T1G3 patients. When there is T1 tumor in the re-TUR specimen, very high risks of progression (82%) have been reported. We analyze the risks of recurrence, progression to muscle-invasive disease and cancer-specific mortality (CSM) according to tumor stage at re-TUR in T1G3 patients treated with BCG.Methods: In our retrospective cohort of 2451 T1G3 patients, 934 patients (38.1%) underwent re-TUR. 667 patients had residual disease (71.4%): Ta in 378 (40.5%), T1 in 289 (30.9%) patients. Times to recurrence, progression and CSM in the three groups were estimated using cumulative incidence functions and compared using the Cox regression model.Results:During a median follow-up of 5.2years, 512 patients recurred. The recurrence rate was significantly higher in patients with a T1 at re-TUR (P<0.001). Progression rates differed according to the pathology at re-TUR, 25.3% in T1, 14.6% in Ta and 14.2% in case of no residual tumor (P<0.001). Similar trends were seen in both patients with and without muscle in the original TUR specimen.Conclusions: Patients with T1G3 tumors and no residual disease or Ta at re-TUR have better recurrence, progression and CSM rates than previously reported, with a CSM rate of 13.1 and a 25.3% progression rate in re-TUR T1 disease. | |
| 650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe |
| 650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng |
| 653 | a Non-muscle invasive bladder cancer | |
| 653 | a Re-transurethral resection of the bladder | |
| 653 | a Recurrence | |
| 653 | a Progression | |
| 700 | 1 | a Pisano, F.u Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain;Osped Citta Salute & Sci Molinette, Dept Urol, Corso Bramante 88, I-10126 Turin, Italy4 aut |
| 700 | 1 | a Sylvester, R.u EORTC Headquarters, Dept Biostat, Brussels, Belgium4 aut |
| 700 | 1 | a Joniau, S.u Univ Hosp Leuven, Oncol & Reconstruct Urol, Dept Urol, Louvain, Belgium4 aut |
| 700 | 1 | a Serretta, V.u Univ Palermo, Dept Surg Oncol & Stomatol Sci, Palermo, Italy4 aut |
| 700 | 1 | a Larre, S.u Univ Oxford, John Radcliffe Hosp, Dept Surg Sci, Oxford, England4 aut |
| 700 | 1 | a Di Stasi, S.u Policlin Tor Vergata Univ Rome, Rome, Italy4 aut |
| 700 | 1 | a van Rhijn, B.u Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands4 aut |
| 700 | 1 | a Witjes, A. J.u Radboud Univ Nijmegen, Med Ctr, Dept Urol, Nijmegen, Netherlands4 aut |
| 700 | 1 | a Grotenhuis, A.u Radboud Univ Nijmegen, Med Ctr, Dept Urol, Nijmegen, Netherlands4 aut |
| 700 | 1 | a Colombo, R.u Univ Vita Salute, Osped S Raffaele, Dipartimento Urol, Milan, Italy4 aut |
| 700 | 1 | a Briganti, A.u Univ Vita Salute, Osped S Raffaele, Dipartimento Urol, Milan, Italy4 aut |
| 700 | 1 | a Babjuk, M.u Univ Praha, Motol Hosp, Dept Urol, Prague, Czech Republic4 aut |
| 700 | 1 | a Soukup, V.u Univ Praha, Motol Hosp, Dept Urol, Prague, Czech Republic4 aut |
| 700 | 1 | a Malmström, Per-Unou Uppsala universitet,Urologkirurgi4 aut0 (Swepub:uu)perunoms |
| 700 | 1 | a Irani, J.u Univ Poitiers, Dept Urol, Ctr Hosp Univ Mil, Poitiers, France4 aut |
| 700 | 1 | a Malats, N.u Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain4 aut |
| 700 | 1 | a Baniel, J.u Rabin Med Ctr, Dept Urol, Tel Aviv, Israel4 aut |
| 700 | 1 | a Mano, R.u Rabin Med Ctr, Dept Urol, Tel Aviv, Israel4 aut |
| 700 | 1 | a Cai, T.u Santa Chiara Hosp, Dept Urol, Trento, Italy4 aut |
| 700 | 1 | a Cha, E. K.u Cornell Univ, Weill Med Coll, Dept Urol, New York, NY 10021 USA4 aut |
| 700 | 1 | a Ardelt, P.u Chirurg Univ Klin, Facharzt Urol, Urol Abt, Freiburg, Germany4 aut |
| 700 | 1 | a Varkarakis, J.u Univ Athens, Sismanoglio Hosp, Dept Urol, Athens, Greece4 aut |
| 700 | 1 | a Bartoletti, R.u Univ Florence, Dept Expt & Clin Med, Florence, Italy4 aut |
| 700 | 1 | a Dalbagni, G.u Mem Sloan Kettering Canc Ctr, Dept Urol, 1275 York Ave, New York, NY 10021 USA4 aut |
| 700 | 1 | a Shariat, S. F.u Med Univ Vienna, Vienna, Austria4 aut |
| 700 | 1 | a Xylinas, E.u Cochin Hosp, Dept Urol, Paris, France4 aut |
| 700 | 1 | a Karnes, R. J.u Mayo Clin, Dept Urol, Rochester, MN USA4 aut |
| 700 | 1 | a Gontero, P.u Osped Citta Salute & Sci Molinette, Dept Urol, Corso Bramante 88, I-10126 Turin, Italy4 aut |
| 710 | 2 | a Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spainb Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain;Osped Citta Salute & Sci Molinette, Dept Urol, Corso Bramante 88, I-10126 Turin, Italy4 org |
| 773 | 0 | t World journal of urologyd : SPRINGERg 36:10, s. 1621-1627q 36:10<1621-1627x 0724-4983x 1433-8726 |
| 856 | 4 | u https://art.torvergata.it/bitstream/2108/213079/1/World%20Journal%20of%20Urology%202018_36_1621_1627.pdf |
| 856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-366942 |
| 856 | 4 8 | u https://doi.org/10.1007/s00345-018-2299-2 |
Hitta via bibliotek
- World journal of urology (Sök värdpublikationen i LIBRIS)
Till lärosätets databas
Hitta mer i SwePub
- Av författaren/redakt...
- Palou, J.
- Pisano, F.
- Sylvester, R.
- Joniau, S.
- Serretta, V.
- Larre, S.
- visa fler...
- Di Stasi, S.
- van Rhijn, B.
- Witjes, A. J.
- Grotenhuis, A.
- Colombo, R.
- Briganti, A.
- Babjuk, M.
- Soukup, V.
- Malmström, Per-U ...
- Irani, J.
- Malats, N.
- Baniel, J.
- Mano, R.
- Cai, T.
- Cha, E. K.
- Ardelt, P.
- Varkarakis, J.
- Bartoletti, R.
- Dalbagni, G.
- Shariat, S. F.
- Xylinas, E.
- Karnes, R. J.
- Gontero, P.
- visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Urologi och njur ...
- Artiklar i publikationen
- World journal of ...
- Av lärosätet
- Uppsala universitet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
